Influence of Cytarabine Metabolic Pathway Polymorphisms in Acute Myeloid Leukemia Induction Treatment

被引：0

作者：

Megias-Vericat, Juan Eduardo ^{[1
,2
]}

Pau, Montesinos ^{[3
]}

Herrero, Maria Jose ^{[2
,4
]}

Moscardo, Federico ^{[3
]}

Boso, Virginia ^{[2
,4
]}

Martinez-Cuadron, David ^{[3
]}

Rojas, Luis ^{[2
,4
]}

Rodriguez-Veiga, Rebeca ^{[3
]}

Hervas, David ^{[5
]}

Boluda, Blanca ^{[3
]}

Sendra, Luis ^{[4
]}

Sanz, Jaime ^{[6
]}

Miguel, Antonio ^{[4
]}

Cervera, Jose ^{[7
]}

Poveda, Jose Luis ^{[1
,2
]}

Alino, Salvador F. ^{[8
,9
,10
]}

Sanz, Miguel Angel ^{[3
]}

机构：

[1] Hosp Univ Politecn Fe, Dept Pharm, Drug Clin Area, Valencia, Spain

[2] Inst Invest Sanitaria Fe, Valencia, Spain

[3] Hosp Univ Politecn Fe, Dept Hematol, Valencia, Spain

[4] Hosp Univ Politecn Fe, Pharmacogenet Unit, Drug Clin Area, Valencia, Spain

[5] Inst Invest Sanitaria Fe, Biostatist Unit, Valencia, Spain

[6] Hosp Univ Politecn Fe, Valencia, Spain

[7] Hosp Univ Politecn Fe, Genet Unit, Hematol Serv, Valencia, Spain

[8] Univ Valencia, Pharmacogenet Unit, Drug Clin Area, Valencia, Spain

[9] Univ Valencia, Clin Pharmacol Unit, Hosp Univ Politec Fe, Valencia, Spain

[10] Univ Valencia, Fac Med, Dept Pharmacol, Valencia, Spain

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.5130.5130

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5130

引用

页数：6

共 50 条

[1] Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment
Eduardo Megias-Vericat, Juan
Montesinos, Pau
Jose Herrero, Maria
Moscardo, Federico
Boso, Virginia
Martinez-Cuadron, David
Rojas, Luis
Rodriguez-Veiga, Rebeca
Boluda, Blanca
Sendra, Luis
Cervera, Jose
Luis Poveda, Jose
Angel Sanz, Miguel
Alino, Salvador F.
LEUKEMIA & LYMPHOMA, 2017, 58 (12) : 2880 - 2894
[2] Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia
Megias-Vericat, Juan E.
Montesinos, Pau
Herrero, Maria J.
Moscardo, Federico
Boso, Virginia
Martinez-Cuadron, David
Poveda, Jose L.
Sanz, Miguel A.
Alino, Salvador F.
PHARMACOGENETICS AND GENOMICS, 2017, 27 (07): : 270 - 274
[3] Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy
Eduardo Megias, Juan
Montesinos, Pau
Boso, Virginia
Moscardo, Federico
Jose Herrero, Maria
Martinez-Cuadron, David
Rodriguez-Veiga, Rebeca
Rojas, Luis
Boluda, Blanca
Martinez, Jesus
Sanz, Jaime
Lopez, Francisca
Cano, Isabel
Alonso, Carmen
Lacharro, Aima
Cervera, Jose
Luis Poveda, Jose
Alino, Salvador
Angel Sanz, Miguel
BLOOD, 2014, 124 (21)
[4] Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia
Eduardo Megias, Juan
Montesinos, Pau
Jose Herrero, Maria
Moscardo, Federico
Boso, Virginia
Martinez-Cuadron, David
Rojas, Luis
Rodriguez-Veiga, Rebeca
Boluda, Blanca
Martinez, Jesus
Sanz, Jaime
Lopez, Francisca
Cano, Isabel
Lancharro, Aima
Cervera, Jose
Hervas, David
Luis Poveda, Jose
Alino, Salvador F.
Angel Sanz, Miguel
BLOOD, 2015, 126 (23)
[5] Induction of Acute Myeloid Leukemia with Idarubicin, Cytarabine and Cladribine
Wiedower, Eric
Jamy, Omer
Martin, Michael G.
ANTICANCER RESEARCH, 2015, 35 (11) : 6287 - 6290
[6] Cytarabine and daunorubicin for the treatment of acute myeloid leukemia
Murphy, Tracy
Yee, Karen W. L.
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (16) : 1765 - 1780
[7] Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy
Amaki, Jun
Onizuka, Makoto
Ohmachi, Ken
Aoyama, Yasuyuki
Hara, Ryujiro
Ichiki, Akifumi
Kawai, Hidetsugu
Sato, Ai
Miyamoto, Mitsuki
Toyosaki, Masako
Machida, Shinichiro
Kojima, Minoru
Shirasugi, Yukari
Kawada, Hiroshi
Ogawa, Yoshiaki
Ando, Kiyoshi
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (06) : 543 - 553
[8] Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy
Jun Amaki
Makoto Onizuka
Ken Ohmachi
Yasuyuki Aoyama
Ryujiro Hara
Akifumi Ichiki
Hidetsugu Kawai
Ai Sato
Mitsuki Miyamoto
Masako Toyosaki
Shinichiro Machida
Minoru Kojima
Yukari Shirasugi
Hiroshi Kawada
Yoshiaki Ogawa
Kiyoshi Ando
International Journal of Hematology, 2015, 101 : 543 - 553
[9] FLUDARABINE, CYTARABINE AND IDARUBICIN FOR INDUCTION TREATMENT OF POOR-RISK ACUTE MYELOID LEUKEMIA
Villa, M. R.
Izzo, G. Nitrato
Gagliardi, A.
Improta, S.
Mastrullo, L.
HAEMATOLOGICA, 2015, 100 : 81 - 81
[10] High-dose cytarabine induction for acute myeloid leukemia
Shepherd, JD
Barnett, MJ
Phillips, GL
BLOOD, 1996, 88 (02) : 754 - 754

← 1 2 3 4 5 →